Biogen | BIIB - Market Capitalization



Biogen reported $20.68B in Market Capitalization this September of 2025, considering the latest stock price and the number of outstanding shares.


Market Capitalization Change Date
AbbVie USD 327.88B 42.76B Jun/2025
Acadia Pharmaceuticals USD 3.61B 840M Jun/2025
ALKERMES USD 4.72B 725M Jun/2025
Amgen USD 150.13B 17.37B Jun/2025
Bayer EUR 25.09B 3.38B Jun/2025
Biogen USD 18.41B 1.62B Jun/2025
BioMarin Pharmaceutical USD 10.54B 3.01B Jun/2025
Bristol-Myers Squibb USD 94.2B 29.9B Jun/2025
Eli Lilly USD 738.79B 2.87B Jun/2025
Gilead Sciences USD 137.91B 1.77B Jun/2025
Incyte USD 13.18B 1.46B Jun/2025
Merck USD 198.77B 27.1B Jun/2025
Moderna USD 10.67B 290M Jun/2025
Neurocrine Biosciences USD 12.44B 1.5B Jun/2025
Novartis CHF 256.18B 64.49B Jun/2025
Pfizer USD 137.53B 6.19B Jun/2025
PTC Therapeutics USD 3.87B 148M Jun/2025
Regeneron Pharmaceuticals USD 55.87B 13.47B Jun/2025
Sanofi EUR 100.06B 25.78B Jun/2025
Sanofi USD 125.19B 7.59B Sep/2025
Sarepta Therapeutics USD 1.68B 4.51B Jun/2025
Teva Pharmaceutical Industries ILS 65.36B 1.34B Jun/2025
Ultragenyx Pharmaceutical USD 3.44B 38M Jun/2025
United Therapeutics USD 12.96B 934M Jun/2025
Vertex Pharmaceuticals USD 114.33B 10.31B Jun/2025